Observational studyJournal of Korean medical science2026
Impact of the COVID-19 Pandemic on Treatment Outcomes and Healthcare Utilization Among People Living With HIV in Korea: A Multicenter Cohort Study.
Observational study in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare delivery worldwide, raising concerns about continuity of care for people living with HIV (PLWH). However, its long-term effect on HIV treatment outcomes in resource-rich settings with robust public health infrastructure remains unclear. Therefore, this study aims to evaluate the effects of the COVID-19 pandemic on virological outcomes, immunological status, healthcare utilization, medication adherence, and mortality among PLWH enrolled in the Korea HIV/AIDS Cohort.
methodsA retrospective longitudinal analysis was conducted using the Korea HIV/AIDS Cohort data collected between 2018 and 2023. Outcomes during the pre-pandemic (2018-2019) and pandemic (2020-2023) periods were compared. The primary outcome was virological failure, defined as an HIV RNA level ≥ 200 copies/mL. Secondary outcomes included CD4+ T-cell count, opportunistic infections, visit adherence (≥ 2 clinic visits/year), all-cause mortality, and visual analog scale-assessed self-reported medication adherence. Repeated-measures analyses were performed using generalized estimating equations with an exchangeable correlation structure, adjusted for age and sex. Mortality risk was evaluated using Cox proportional hazards models, with subgroup and sensitivity analyses also performed.
resultsOverall, 1,674 patients contributed 9,721 visits. Virological failure decreased from 3.2% pre-pandemic to 1.2% during the pandemic (adjusted odds ratio [OR], 0.37; 95% confidence interval [CI], 0.27-0.50;
conclusionDespite reduced clinic utilization during the COVID-19 pandemic, PLWH in Korea maintained or improved virological and immunological outcomes. These observational findings support the feasibility of less intensive monitoring for selected virologically stable individuals. However, given the potential for survivorship bias and unmeasured confounding, prospective studies are required before changes to monitoring practice can be recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.